Shopping Cart
Remove All
Your shopping cart is currently empty
Ozuriftamab vedotin is an antibody‑drug conjugate (ADC) composed of the conditionally active biologic (CAB) — humanized anti-receptor tyrosine kinase-like orphan receptor 2 (ROR2) monoclonal antibody Ozuriftamab — conjugated to VcMMAE, with antitumor activity.

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $398 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $998 | 2-4 weeks | 2-4 weeks | |
| 10 mg | Preferential | 2-4 weeks | 2-4 weeks |
| Description | Ozuriftamab vedotin is an antibody‑drug conjugate (ADC) composed of the conditionally active biologic (CAB) — humanized anti-receptor tyrosine kinase-like orphan receptor 2 (ROR2) monoclonal antibody Ozuriftamab — conjugated to VcMMAE, with antitumor activity. |
| Synonyms | CAB-ROR2-ADC, BA3021, BA 3021, Anti-ROR2 ADC |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal, ADC |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | MMAE |
| Gene ID | |
| Uniprot ID | |
| Target | ROR2 |
| Cas No. | 2460400-11-5 |
| Isotype | IgG1 |
| Storage | Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.